Ori Gutwerg
CIK: 0001846478
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ANI PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Aug 10, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct3.2K shares at avg. $77.00$243K - May 12, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct2.8K shares at avg. $79.50$220K - Mar 7, 2026ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct3.3K shares at avg. $74.04$245K - Mar 3, 2026ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct2.1K shares at avg. $76.50$158K - Feb 28, 2026ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct2.2K shares at avg. $73.90$164K - Feb 26, 2026ANIP
ANI PHARMACEUTICALS INC
Award(A)Direct13K shares at avg. $77.15$1.0M - Feb 14, 2026ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct1.9K shares at avg. $77.36$146K - Feb 12, 2026ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct1.8K shares at avg. $76.70$136K - Feb 11, 2026ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct4.3K shares at avg. $76.25$325K - Aug 12, 2025ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct5.9K shares at avg. $86.53$508K - May 15, 2025ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct881 shares at avg. $60.07$53K - Mar 7, 2025ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct3.3K shares at avg. $60.62$201K - Mar 5, 2025ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct5.1K shares at avg. $60.00$305K - Mar 5, 2025ANIP
ANI PHARMACEUTICALS INC
Exercise(M)Direct300 shares at avg. $31.49$9K - Mar 5, 2025ANIP
ANI PHARMACEUTICALS INC
Sale(S)Direct300 shares at avg. $60.03$18K - Feb 28, 2025ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct1.6K shares at avg. $61.89$97K - Feb 15, 2025ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct1.2K shares at avg. $58.92$69K - Feb 14, 2025ANIP
ANI PHARMACEUTICALS INC
Tax Payment(F)Direct1.4K shares at avg. $58.92$84K - Feb 12, 2025ANIP
ANI PHARMACEUTICALS INC
Award(A)Direct10.4K shares- - Feb 12, 2025ANIP
ANI PHARMACEUTICALS INC
Award(A)Direct15.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 3,162 | $77.00 | $243,474 | Direct |
| May 12, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 2,772 | $79.50 | $220,374 | Direct |
| Mar 7, 2026 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 3,314 | $74.04 | $245,369 | Direct |
| Mar 3, 2026 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 2,060 | $76.50 | $157,590 | Direct |
| Feb 28, 2026 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 2,221 | $73.90 | $164,132 | Direct |
| Feb 26, 2026 | ANIP ANI PHARMACEUTICALS INC | Award(A) | 12,969 | $77.15 | $1,000,558 | Direct |
| Feb 14, 2026 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 1,888 | $77.36 | $146,056 | Direct |
| Feb 12, 2026 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 1,775 | $76.70 | $136,143 | Direct |
| Feb 11, 2026 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 4,267 | $76.25 | $325,359 | Direct |
| Aug 12, 2025 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 5,873 | $86.53 | $508,191 | Direct |
| May 15, 2025 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 881 | $60.07 | $52,922 | Direct |
| Mar 7, 2025 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 3,314 | $60.62 | $200,895 | Direct |
| Mar 5, 2025 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 5,084 | $60.00 | $305,040 | Direct |
| Mar 5, 2025 | ANIP ANI PHARMACEUTICALS INC | Exercise(M) | 300 | $31.49 | $9,447 | Direct |
| Mar 5, 2025 | ANIP ANI PHARMACEUTICALS INC | Sale(S) | 300 | $60.03 | $18,009 | Direct |
| Feb 28, 2025 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 1,570 | $61.89 | $97,167 | Direct |
| Feb 15, 2025 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 1,167 | $58.92 | $68,760 | Direct |
| Feb 14, 2025 | ANIP ANI PHARMACEUTICALS INC | Tax Payment(F) | 1,426 | $58.92 | $84,020 | Direct |
| Feb 12, 2025 | ANIP ANI PHARMACEUTICALS INC | Award(A) | 10,444 | - | - | Direct |
| Feb 12, 2025 | ANIP ANI PHARMACEUTICALS INC | Award(A) | 15,668 | - | - | Direct |
1-20 of 20 transactions
About Gutwerg Ori
Gutwerg Ori (SEC CIK 0001846478) files insider reports with the SEC as SVP, GENERICS of ANI PHARMACEUTICALS INC (ANIP).
Signal8 holds 13 ownership filings by Gutwerg Ori, all Form 4s, filed between Feb 18, 2025 and Aug 11, 2026. Those filings report 20 transactions, from Feb 12, 2025 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gutwerg Ori's filings is in PRINCETON, NJ.
Recent filings by Gutwerg Ori
- Aug 10, 2026: Open-market sale of ANIP shares (Form 4, code S).
- May 12, 2026: Open-market sale of ANIP shares (Form 4, code S).
- Mar 7, 2026: Tax withholding of ANIP shares (Form 4, code F).
- Mar 3, 2026: Open-market sale of ANIP shares (Form 4, code S).
- Feb 28, 2026: Tax withholding of ANIP shares (Form 4, code F).
Other insiders filing for ANI PHARMACEUTICALS INC (ANIP)
- CAREY STEPHEN P., SVP & CFO
- Lalwani Nikhil, PRESIDENT & CEO
- Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.
- Thoma Jeanne, Director
- Gosebruch Henry O, Director
- TANNENBAUM RENEE P, Director